Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
About this item
Full title
Author / Creator
Li, Qingrong , Ma, Qiang , Cheng, Jibing , Zhou, Xi , Pu, Wenjie , Zhong, Xiaowu and Guo, Xiaolan
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Cancer is one of the major threats to human health. Although humans have struggled with cancer for decades, the efficacy of treatments for most tumors is still very limited. Dihydroartemisinin (DHA) is a derivative of artemisinin, a first-line antimalarial drug originally developed in China. Beyond the anti-malarial effect, DHA has also been report...
Alternative Titles
Full title
Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8053502
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8053502
Other Identifiers
ISSN
1178-6930
E-ISSN
1178-6930
DOI
10.2147/OTT.S297785
